Marco Lenzi

Preliminary classification criteria for the cryoglobulinaemic vasculitis

A. Gabrielli, S. Bombardieri, D. Sansonno, 2011, Annals of the rheumatic diseases.

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

A. Gabrielli, S. Bombardieri, D. Roccatello, 2012, Arthritis and rheumatism.

OP0227 Oral C5a Receptor Antagonist CCX168 Phase 2 Clinical TRIAL in Anca-Associated Renal Vasculitis

S. Baldovino, L. Quartuccio, A. Tavoni, 2014 .

A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2.

A. Alberti, F. Pero, M. Lenzi, 2001, Blood.

Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim‐like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis

R. Chapman, C. De Molo, A. Granito, 2006, Alimentary pharmacology & therapeutics.

Clinical features of type 1 autoimmune hepatitis in elderly Italian patients

A. Granito, M. Lenzi, G. Pappas, 2005, Alimentary pharmacology & therapeutics.